1) cage degradation
笼体降解
2) degradation in vitro
体外降解
1.
In this paper,the effect of polymerization condition on intrinsic viscosity( η ) of polydioxanone and conversion for the polymerization of dioxanone was investigated, and the hydrolytic degradation in vitro of polydioxanone suture was studied.
研究了合成条件对聚对二氧杂环己酮特性粘度和转化率的影响，及其由聚合物制作的缝线的体外降解性能。
3) in vitro degradation
体外降解
1.
Study on the in vitro degradation of poly(propylene fumarate)/(calcium sulfate/β-tricalcium phosphate) biocomposites
聚富马酸丙二醇酯/(硫酸钙/β-磷酸三钙)生物复合材料的体外降解研究
2.
Properties of polyglycolic acid fiber in vitro degradation
聚乙交酯纤维的体外降解性能
3.
The in vitro degradation of the crosslinked composites formed by unsaturated polyphosphoester(UPPE)、N-vinyl pyrrolidone(NVP) and β-tricalcium phosphate(β-TCP) was investigated and the surface morphology of dagradation sample was imaged by scanning electron microscopy(SEM).
研究了不饱和聚磷酸酯(UPPE)、N-乙烯基吡咯烷酮(NVP)与β-磷酸钙(β-TCP)交联复合体系的体外降解过程,并用扫描电镜观察了降解一定时间后试样表面的形貌结构。
4) vitro degradation
体外降解
1.
Research on in vitro degradation of β-TCP/PLLA internal fracture fixation composite material;
β-磷酸三钙/聚左旋乳酸骨折内固定材料的体外降解性能研究
6) degradation
[英][,deɡrə'deɪʃn] [美]['dɛgrə'deʃən]
体外降解
1.
To select the best scale of β-TCP toβ-TCP /PDLLA by the degradation experiment in vitro;
体外降解实验筛选骨修复材料β-TCP/DLPLA最适比例
2.
Preparation, Degradation and Cytocompatibility of Poly-L-lactic Acid (PLLA) Scaffold for Cartilage Tissue Engineering;
本文以聚-L-乳酸(PLLA)为原料,研究了多孔支架的制备、体外降解和软骨细胞的相容性。
补充资料：笼体降解
分子式：
CAS号：
性质：三角多面体骨架(如硼烷)去除骨架顶角的过程。如[NMe4]B5H8(戊硼烷(8)四甲基胺盐)+ 6PrOH(异丙醇)→[NMe4]B3H8(丙硼烷(8)四甲基胺)+2B(OPri)3(异丙醇硼)+3H2(氢)和B5H9(戊硼烷(9))+B5H9(TMED)( 戊硼烷(9))B4H8(TMED)( 丁硼烷(8))+2B(OMe)3(三甲氧基硼)+2H2(氢)(Pri为异丙烷CH3CHCH3，TMED为N,N-二甲基乙二胺(Me2NCH2CH2NMe2)
CAS号：
性质：三角多面体骨架(如硼烷)去除骨架顶角的过程。如[NMe4]B5H8(戊硼烷(8)四甲基胺盐)+ 6PrOH(异丙醇)→[NMe4]B3H8(丙硼烷(8)四甲基胺)+2B(OPri)3(异丙醇硼)+3H2(氢)和B5H9(戊硼烷(9))+B5H9(TMED)( 戊硼烷(9))B4H8(TMED)( 丁硼烷(8))+2B(OMe)3(三甲氧基硼)+2H2(氢)(Pri为异丙烷CH3CHCH3，TMED为N,N-二甲基乙二胺(Me2NCH2CH2NMe2)
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条